Medicare Enrolled

Dr. Eugene Wyszynski, DO

Hematology & Oncology · Farmers Branch, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
9 MEDICAL PKWY STE 210, Farmers Branch, TX 75234
2144496511
Registered in NPPES since 2006
NPI: 1760431845 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wyszynski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wyszynski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wyszynski

Dr. Eugene Wyszynski is a hematology & oncology specialist in Farmers Branch, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wyszynski performed 99 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Wyszynski received a total of $19,134 from 76 pharmaceutical and/or device companies across 608 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wyszynski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 99 Medicare services $19,134 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
99
Medicare services
Bottom 7% in TX for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$126
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
76 $134 $388
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
23 $99 $263
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$19,134
Total received (2018-2024)
Avg $2,733/year across 7 years
Top 21% in TX for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
76
Companies
608
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$415
2023
$781
2022
$3,324
2021
$2,762
2020
$1,465
2019
$3,715
2018
$6,671

Payments by company (2024)

Madrigal Pharmaceuticals
$130
Incyte Corporation
$100
Janssen Biotech, Inc.
$81
Novartis Pharmaceuticals Corporation
$42
Mindray DS USA, Inc.
$39
Adaptive Biotechnologies Corporation
$23
Top 3 companies account for 75.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,735
Novartis Pharmaceuticals Corporation
$2,442
Amgen Inc.
$2,387
Janssen Biotech, Inc.
$1,978
Incyte Corporation
$1,088
PFIZER INC.
$982
E.R. Squibb & Sons, L.L.C.
$585
Astellas Pharma US Inc
$576
Merck Sharp & Dohme Corporation
$481
Deciphera Pharmaceuticals Inc.
$455
Takeda Pharmaceuticals U.S.A., Inc.
$337
Celgene Corporation
$326
EISAI INC.
$243
Gilead Sciences, Inc.
$230
Eisai Inc.
$220
Pharmacyclics LLC, An AbbVie Company
$204
Foundation Medicine, Inc.
$193
Sirtex Medical Inc
$179
NOVARTIS PHARMACEUTICALS CORPORATION
$167
Blueprint Medicines Corporation
$164
Octapharma USA, Inc.
$163
Rigel Pharmaceuticals, Inc.
$156
Genentech USA, Inc.
$146
Madrigal Pharmaceuticals
$130
Boehringer Ingelheim Pharmaceuticals, Inc.
$124
Kowa Pharmaceuticals America, Inc.
$124
EMD Serono, Inc.
$119
Kite Pharma, Inc.
$118
Taiho Oncology, Inc.
$110
Janssen Products, LP
$100
Bayer HealthCare Pharmaceuticals Inc.
$97
Dova Pharmaceuticals
$94
Acrotech Biopharma LLC
$88
Ipsen Biopharmaceuticals, Inc
$80
Daiichi Sankyo Inc.
$78
Exelixis Inc.
$78
Lexicon Pharmaceuticals, Inc.
$78
Regeneron Healthcare Solutions, Inc.
$75
Sun Pharmaceutical Industries Inc.
$68
GENZYME CORPORATION
$60
Merck Sharp & Dohme LLC
$59
Karyopharm Therapeutics Inc.
$56
INSYS Therapeutics Inc
$53
Genentech, Inc.
$50
Teva Pharmaceuticals USA, Inc.
$47
AbbVie, Inc.
$47
Myovant Sciences Inc.
$46
Clovis Oncology, Inc.
$45
Coherus Biosciences Inc.
$40
AMAG Pharmaceuticals, Inc.
$39
Mindray DS USA, Inc.
$39
Sobi, Inc
$38
GlaxoSmithKline, LLC.
$36
TESARO, Inc.
$36
AngioDynamics, Inc.
$35
Advanced Accelerator Applications
$34
ARRAY BIOPHARMA INC
$31
Janssen Pharmaceuticals, Inc
$27
MEDIVATION FIELD SOLUTIONS LLC
$24
Adaptive Biotechnologies Corporation
$23
MENARINI SILICON BIOSYSTEMS, INC.
$22
Bio Products Laboratory USA, Inc.
$21
Accord Healthcare, Inc.
$21
Heron Therapeutics, Inc.
$21
Kyowa Kirin, Inc.
$19
Dendreon Pharmaceuticals LLC
$19
Verity Pharmaceuticals Inc.
$18
EUSA Pharma (US) LLC
$18
Shire North American Group Inc
$17
Alnylam Pharmaceuticals Inc.
$16
Stemline Therapeutics Inc.
$15
Helsinn Therapeutics (U.S.), Inc.
$15
Spectrum Pharmaceuticals Inc.
$14
Seattle Genetics, Inc.
$12
Tactile Systems Technology Inc
$12
Epizyme, Inc.,
$11
Top 3 companies account for 39.5% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · AYVAKIT · Alecensa · Aliqopa · Avastin · BELEODAQ · BENDEKA · BOSULIF · BRAFTOVI · Bavencio · CALQUENCE · CAMCEVI · Cabometyx · Cellsearch · DARZALEX · DOPTELET · Doptelet · ELITEK · ELZONRIS · ENHERTU · ERLEADA · EVENITY · Enhertu · Erivedge · Erleada · FARESTON · FERAHEME · FOUNDATIONACT · FOUNDATIONONE · Flexitouch Plus · Folotyn · GAVRETO · GILOTRIF · GIVLAARI · Gammaplex · HYQVIA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INQOVI · INREBIC · Imbruvica · JADENU · JAKAFI · JARDIANCE · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Livalo · Lonsurf · MEKINIST · MONJUVI · MVASI · NINLARO · NUWIQ · Neulasta · Nplate · Nubeqa · ODOMZO · OPDIVO · OPDUALAG · ORGOVYX · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PROMACTA · PROVENGE · Perjeta · Pomalyst · QINLOCK · REBLOZYL · REZDIFFRA · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TAZVERIK · TE7 MAX · TECENTRIQ · Tavalisse · Trelstar · Trodelvy · Udenyca · VOTRIENT · Vectibix · Venclexta · Vitrakvi · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xtandi · YERVOY · YONSA · Yescarta · ZEJULA · ZYTIGA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Farmers Branch?
Compare hematology & oncology specialists in the Farmers Branch area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
136
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
DALLAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wyszynski is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wyszynski experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Wyszynski performed 76 office visit, established patient, complex (40-54 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Wyszynski receive payments from pharmaceutical companies?
Yes. Dr. Wyszynski received a total of $19,134 from 76 companies across 608 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wyszynski's costs compare to other hematology & oncology specialists in Farmers Branch?
Dr. Wyszynski's average Medicare payment per service is $126. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wyszynski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →